Schroders Cap Share News (INOV)

TRADING UPDATES: Home REIT cuts borrowings, Genflow shares restored

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday, and not separately reported by Alliance News:

SMALL-CAP WINNERS & LOSERS: ProCook rises on higher quarterly revenue

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

IN BRIEF: Schroders Capital Global receives Carmot sale distribution

Schroders Capital Global Innovation Trust PLC - London-based investment trust focused on a portfolio of "highly innovative" companies - Receives a USD5.6 million payment from Basel, Switzerland-based pharmaceutical firm, Roche Holding AG, in relation to the sale of its portfolio company Carmot Therapeutics Inc. Carmot is a Berkley, California-based biotechnology company currently focused on developing treatments for obesity and diabetes. In December, Carmot entered into an agreement to be acquired by Roche for a USD2.7 billion purchase price, alongside up to USD400 million in milestone payments. Schroders says that the USD5.6 million distribution represents a 221% fair value uplift relative to the value of its holding in Carmot of GBP1.4 million in September.

Schroders Capital Global Innovation injects USD1.6 million in Neurona

(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday said it had made an investment of USD1.6 million in California-based clinical-stage cell therapy company Neurona Therapeutics.

IN BRIEF: Schroders Capital Global Innovation gets sale milestone fee

Schroders Capital Global Innovation Trust PLC - London-based investment trust with a diversified portfolio of global private and public equity companies - Receives USD5.8 million distribution related to the first milestone of the Kymab sale to Sanofi SA. In April 2021, Schroders Capital Global Innovation completed the sale of its shares in Kymab to Sanofi for initial proceeds of USD87 million. Company says: "At that time, the company explained there was the potential for additional contingent payments of up to USD27 million subject to the achievement of various development and regulatory milestones. This announced payment reflects the first milestone event, with the potential for USD21 million of further contingent payments in the future."

Schroders Capital notes Roche buys portfolio firm for USD2.7 billion

(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday noted that its portfolio company Carmot Therapeutics Inc has been acquired by Roche Holding AG.

TRADING UPDATES: Begbies to meet expectations; McBride shines

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

SMALL-CAP WINNERS & LOSERS: Foxtons shares rise on pressure to sell

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

TRADING UPDATES: BiVictriX patent boost; 4Global deal extended

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Schroder Capital Global re-values Atom Bank after fundraise

Schroders Capital Global Innovation Trust PLC - London-based investment trust focused on a diversified portfolio of global private and public equity companies - Says that its portfolio company, Atom Bank, has raised GBP100 million in new equity capital from existing shareholders BBVA, Toscafund and Infinity Investment Partners. The funds will be used to accelerate lending and balance sheet growth as the bank continues to scale. Following this, Schroders says its holding in Atom Bank has been revalued to GBP23.1 million. Explains that this revaluation will result in a negative fair value impact of GBP8.6 million relative, to the holding value as of June 30 of GBP31.7 million.

IN BRIEF: Schroders Capital Global invests in Securiti

Schroders Capital Global Innovation Trust PLC - Invests in US-based cybersecurity company, Securiti, but does not provide further financial details. "We believe Securiti is playing a key role in transforming how organisations can innovate with vast quantities of data while meeting their data obligations, and we are delighted to make this investment to accelerate the company's progress," it says.

TRADING UPDATES: Schroders Capital Global investee to be bought out

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: